Literature DB >> 17328945

Modafinil improves attention, inhibitory control, and reaction time in healthy, middle-aged rats.

Russell E Morgan1, Jaime M Crowley, Roland H Smith, Ronee B LaRoche, Marsha M Dopheide.   

Abstract

This study examined the effect of the novel psychostimulant modafinil (Provigil) on a variety of cognitive and behavioral measures including associative learning, sustained attention, inhibitory control, and reaction time. Middle-aged female rats (18-20 months old) were administered oral doses of modafinil (0, 8, 32, and 64 mg/kg) and tested in a 3-choice visual discrimination and sustained attention task. Modafinil produced a dose-dependent pattern of improved response accuracy and impulse control (fewer premature responses) and shorter response latencies, without affecting omission errors, motivation or motor control. Although the biochemical mechanism of modafinil is unknown, these results suggest a profile differing from typical psychostimulants (e.g., amphetamine). The implications of these findings for treatment of narcolepsy, ADHD, and various arousal-related disorders are considered. Further research is needed to examine the relative safety, effectiveness, and addictive potential of modafinil, as well as, its effects in comparison with other performance-enhancing drugs (e.g., caffeine, nicotine, and amphetamines).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328945     DOI: 10.1016/j.pbb.2007.01.015

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  19 in total

1.  Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse.

Authors:  Carmela M Reichel; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

2.  Wake-promoting agent modafinil worsened attentional performance following REM sleep deprivation in a young-adult rat model of 5-choice serial reaction time task.

Authors:  Yia-Ping Liu; Che-Se Tung; Yu-Lung Lin; Chia-Hsin Chuang
Journal:  Psychopharmacology (Berl)       Date:  2010-09-24       Impact factor: 4.530

3.  Modafinil prevents inhibitory avoidance memory deficit induced by sleep deprivation in rats.

Authors:  Karin Monteiro Moreira; Tatiana Lima Ferreira; Debora Cristina Hipolide; Raquel Vecchio Fornari; Sergio Tufik; Maria Gabriela Menezes Oliveira
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

Review 4.  The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.

Authors:  Catharine A Winstanley
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 5.  The likelihood of cognitive enhancement.

Authors:  Gary Lynch; Linda C Palmer; Christine M Gall
Journal:  Pharmacol Biochem Behav       Date:  2011-01-06       Impact factor: 3.533

Review 6.  Sleep disorders, obesity, and aging: the role of orexin.

Authors:  Joshua P Nixon; Vijayakumar Mavanji; Tammy A Butterick; Charles J Billington; Catherine M Kotz; Jennifer A Teske
Journal:  Ageing Res Rev       Date:  2014-11-22       Impact factor: 10.895

Review 7.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

8.  Modafinil and memory: effects of modafinil on Morris water maze learning and Pavlovian fear conditioning.

Authors:  Tristan Shuman; Suzanne C Wood; Stephan G Anagnostaras
Journal:  Behav Neurosci       Date:  2009-04       Impact factor: 1.912

9.  Depression-like deficits in rats improved by subchronic modafinil.

Authors:  Ralf Regenthal; Holger Koch; Christian Köhler; Rainer Preiss; Ute Krügel
Journal:  Psychopharmacology (Berl)       Date:  2009-03-03       Impact factor: 4.530

10.  MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs.

Authors:  Adam C Mar; Simon R O Nilsson; Begoña Gamallo-Lana; Ming Lei; Theda Dourado; Johan Alsiö; Lisa M Saksida; Timothy J Bussey; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2017-07-26       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.